Vivani Medical, Inc. Increase (Decrease) in Deferred Revenue
Vivani Medical, Inc. (VANI) reported Increase (Decrease) in Deferred Revenue of $114.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2018-11-08
- Vivani Medical, Inc. increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was $114.00K, a 59.57% decline year-over-year.
- Vivani Medical, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-12-31 was $63.00K.
- Vivani Medical, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-09-30 was $0.00.
- Vivani Medical, Inc. increase (decrease) in deferred revenue for the quarter ending 2017-06-30 was -$386.00K.
- Vivani Medical, Inc. increase (decrease) in deferred revenue for fiscal 2017 was -$41.00K.
- Vivani Medical, Inc. increase (decrease) in deferred revenue for fiscal 2016 was -$234.00K.
- Vivani Medical, Inc. increase (decrease) in deferred revenue for fiscal 2015 was -$278.00K, a 152.35% decline from fiscal 2014.
- Vivani Medical, Inc. increase (decrease) in deferred revenue for fiscal 2014 was $531.00K.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 3 month as first filed | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 6 month as first filed | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 9 month as first filed | Increase (Decrease) in Deferred Revenue 12 month |
|---|---|---|---|---|---|---|---|
| 2018-03-31 | $114.00K 10-Q · filed 2018-05-15 | $177.00K derived: sum of 2 quarters · filed 2018-05-15 | $177.00K derived: sum of 3 quarters · filed 2018-11-08 | -$209.00K derived: sum of 4 quarters · filed 2018-11-08 | |||
| 2017-12-31 | $63.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | $63.00K derived: sum of 2 quarters · filed 2018-11-08 | -$323.00K derived: sum of 3 quarters · filed 2018-11-08 | -$41.00K 10-K · filed 2018-03-20 | |||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$386.00K derived: sum of 2 quarters · filed 2018-11-08 | -$104.00K 10-Q · filed 2018-11-08 | -$25.00K 10-Q · filed 2017-11-06 | -$203.00K derived: sum of 4 quarters · filed 2018-11-08 | ||
| 2017-06-30 | -$386.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$104.00K 10-Q · filed 2018-08-07 | $56.00K 10-Q · filed 2017-08-07 | -$203.00K derived: sum of 3 quarters · filed 2018-08-07 | -$277.00K derived: sum of 4 quarters · filed 2018-08-07 | ||
| 2017-03-31 | $282.00K 10-Q · filed 2018-05-15 | $183.00K derived: sum of 2 quarters · filed 2018-05-15 | $109.00K derived: sum of 3 quarters · filed 2018-05-15 | $52.00K derived: sum of 4 quarters · filed 2018-05-15 | |||
| 2016-12-31 | -$99.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | -$173.00K derived: sum of 2 quarters · filed 2018-03-20 | -$230.00K derived: sum of 3 quarters · filed 2018-03-20 | -$234.00K 10-K · filed 2018-03-20 | |||
| 2016-09-30 | -$74.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$131.00K derived: sum of 2 quarters · filed 2017-11-06 | -$135.00K 10-Q · filed 2017-11-06 | -$597.00K derived: sum of 4 quarters · filed 2018-03-20 | |||
| 2016-06-30 | -$57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | -$61.00K 10-Q · filed 2017-08-07 | -$523.00K derived: sum of 3 quarters · filed 2018-03-20 | -$644.00K derived: sum of 4 quarters · filed 2018-03-20 | |||
| 2016-03-31 | -$4.00K 10-Q · filed 2017-05-09 | -$4.00 10-Q · filed 2016-05-06 | -$466.00K derived: sum of 2 quarters · filed 2018-03-20 | -$587.00K derived: sum of 3 quarters · filed 2018-03-20 | -$282.20K derived: sum of 4 quarters · filed 2018-03-20 | ||
| 2015-12-31 | -$462.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-20 | -$583.00K derived: sum of 2 quarters · filed 2018-03-20 | -$278.20K derived: sum of 3 quarters · filed 2018-03-20 | -$278.00K 10-K · filed 2018-03-20 | |||
| 2015-09-30 | -$121.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $183.79K derived: sum of 2 quarters · filed 2016-11-04 | $184.00K 10-Q · filed 2016-11-04 | $183.55K 10-Q · filed 2015-11-16 | $177.07K derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-06-30 | $304.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $305.00K 10-Q · filed 2016-08-08 | $305.17K 10-Q · filed 2015-08-05 | $298.07K derived: sum of 3 quarters · filed 2017-03-16 | $531.49K derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-03-31 | $205.00 10-Q · filed 2016-05-06 | $205.41K 10-Q · filed 2015-05-15 | -$6.72K derived: sum of 2 quarters · filed 2017-03-16 | $226.69K derived: sum of 3 quarters · filed 2017-03-16 | $519.97K derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2014-12-31 | -$6.93K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $226.49K derived: sum of 2 quarters · filed 2017-03-16 | $519.77K derived: sum of 3 quarters · filed 2017-03-16 | $531.00K 10-K · filed 2017-03-16 | |||
| 2014-09-30 | $233.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-16 | $526.70K derived: sum of 2 quarters · filed 2015-11-16 | $537.93K 10-Q · filed 2015-11-16 | ||||
| 2014-06-30 | $293.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $304.51K 10-Q · filed 2015-08-05 | |||||
| 2014-03-31 | $11.23K 10-Q · filed 2015-05-15 | ||||||
| 2013-12-31 | -$98.00K 10-K · filed 2016-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| IRIDEX CORP (IRIX) | United States | $0.011B |